Skip to main content
. Author manuscript; available in PMC: 2024 Feb 7.
Published in final edited form as: Int J Gynecol Cancer. 2023 Aug 7;33(8):1208–1214. doi: 10.1136/ijgc-2023-004491

Table 3.

Summary of adverse events.

Dose Level 1 (n=4) Dose Level −1 (n=5)
AE All grades Grade 3–4 All grades Grade 3–4
Nausea 4 0 4 0
Diarrhea 3 2 4 1
Fatigue 3 0 3 0
Hypomagnesemia 3 0 0 0
Thrombocytopenia 3 1 0 0
Anemia 3 0 0 0
Anorexia 3 0 0 0
Abdominal pain 2 0 1 0
Creatinine increased 2 0 1 0
Hyponatremia 2 1 0 0
Neutropenia 1 1 1 1
Lymphopenia 1 1 1 1
Hypoalbuminemia 1 1 0 0
Vomiting 1 0 4 0
Dermatitis 0 0 3 0
Alanine aminotransferase 0 0 1 0